Ulta Beauty pairs stronger earnings growth and high capital returns with a midrange valuation, but subdued traffic and margin pressure keep execution in focus.
Ulta Beauty's 20.7% three-month rally is backed by stronger Q2 results and raised guidance, but flat traffic, promotions and margins test further gains.
Ulta Beauty (ULTA) is rated Buy, trading at a discount to intrinsic value with strong growth prospects despite near-term consumer pressures. ULTA's expansion strategy includes private label growth, wellness category entry, and continued omnichannel and international development, supporting long-term margin and revenue gains. Financials remain robust: double-digit EPS growth, virtually no long-term financial debt, aggressive buybacks (~7.7% yield), and raised FY26 guidance across all key metrics.
QRG Capital Management Inc. lowered its stake in shares of Ulta Beauty Inc. (NASDAQ: ULTA) by 51.6% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,391 shares of the specialty retailer's stock after selling 3,622 shares
Investors with an interest in Retail - Miscellaneous stocks have likely encountered both Petco Health & Wellness (WOOF) and Ulta Beauty (ULTA). But which of these two companies is the best option for those looking for undervalued stocks?
The sale of 2,000 shares realized ~$1.1 million at a weighted average price of $545.88 per share. The transaction involved shares equal to 5% of the CEO's equity stake held before the filing.
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (âAdagioâ or âthe Companyâ), a leading innovator in catheter ablation technologies for the treatment of car
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.